POSA370 Healthcare Resource Use By European Patients Enrolled in RA-be-Real: A Multinational, Prospective, Observational Study of the Effectiveness, Healthcare Resource Utilization and Costs in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic or Biologic Disease Modifying Therapies - Alten, R; Burmester, G; Matucci-Cerinic, M; Salmon, JH; Zaremba-Pechmann, L; Fakhouri, W; de La Torre, I; Herrera, M; Holzkämper, T; Fautrel, B (Value in Health, 2022)